Skip to main content

Day: May 30, 2023

urban-gro, Inc. Announces Upcoming Conference Participation

LAFAYETTE, Colo., May 30, 2023 (GLOBE NEWSWIRE) — urban-gro, Inc. (Nasdaq: UGRO) (“urban-gro” or the “Company”), an integrated professional services and design-build firm offering solutions to the Controlled Environment Agriculture (“CEA”) and commercial sectors, today announced its participation in the following June conferences.20th Annual Craig-Hallum Institutional Investor Conference, Minneapolis, MN, May 30-31: Bradley Nattrass, Chairman & CEO and Dan Droller, EVP of Corporate Development & Investor Relations, will be participating in one-on-one investor meetings.GAPPA 2023 (formerly Georgia Association of Physical Plant Administrators), Jekyll Island, Georgia, May 27-31: urban-gro will be exhibiting at Booth 101 and hosting several networking events with facilities professionals representing K-12, higher education,...

Continue reading

Stellar Bancorp, Inc. Announces Transfer Of Listing Of Common Stock To The New York Stock Exchange

HOUSTON, May 30, 2023 (GLOBE NEWSWIRE) — Stellar Bancorp, Inc. (the “Company”) (NASDAQ: STEL) announced today that it is transferring the listing of its common stock to the New York Stock Exchange (“NYSE”) from The Nasdaq Stock Market LLC (“Nasdaq”). Stellar common stock is expected to begin trading on the NYSE on Monday, June 12, 2023 and will continue to be traded under the ticker symbol “STEL”. The Company expects its common stock to continue to trade on Nasdaq until the close of the market on June 9, 2023. “We are thrilled to join the NYSE alongside many of the world’s most established and well regarded companies that trade on the NYSE. We believe that the NYSE is the right partner for Stellar and we look forward to leveraging the highly visible NYSE platform as we continue to build long-term value for our shareholders and...

Continue reading

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

TAMPA, Fla. and MENLO PARK, Calif., May 30, 2023 (GLOBE NEWSWIRE) — Morphogenesis, Inc. (“Morphogenesis”), a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to current immunotherapies, and CohBar, Inc. (NASDAQ: CWBR) (“CohBar”), today announced that Morphogenesis’ abstract has been accepted for poster presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 2-6, 2023 in Chicago, IL. Details of the presentation are as follows: Title: Phase 1b trial of IFx-Hu2.0, a novel personalized cancer vaccine, in checkpoint inhibitor resistant Merkel cell carcinoma and cutaneous squamous cell carcinomaAbstract #: 9534Presenter: Andrew Brohl, MD, H. Lee Moffitt Cancer Center and...

Continue reading

Clear Blue Technologies Announces First Quarter Fiscal 2023 Financial Results

Strong 2023 Order Momentum Continues TORONTO, May 30, 2023 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (TSXV: CBLU) (FRANKFURT: OYA) (OTCQB: CBUTF), announces its financial results for the quarter ended March 31, 2023 (“Q1 F2023”). A complete set of Financial Statements and Management’s Discussion & Analysis (“MD&A”) has been filed at www.sedar.com. All dollar amounts are denominated in Canadian dollars. On a Trailing Four Quarter (“TFQ”) basis:TFQ revenue was $1,674,003, a 72% decrease from $5,914,758 in the corresponding previous period. The current period was impacted by the economic downturn triggered by the macro-economic events of early 2022. TFQ recurring revenue was $865,610, a 75% increase from $495,404 in the corresponding previous period. TFQ Gross Profit decreased to $574,296 compared to...

Continue reading

Freeline Reports First Quarter 2023 Financial Results and Business Highlights

Expect to report initial clinical data for FLT201 in Gaucher disease in third quarter of 2023 FLT201 granted ILAP designation, which aims to accelerate time to market and facilitate patient access in the UK for medicines that address significant unmet needs Regained compliance with Nasdaq listing requirements LONDON, May 30, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today reported financial results for the first quarter of 2023 and provided a business update. “FLT201 is a potential first- and best-in-class gene therapy for people with Gaucher disease, potentially improving clinical outcomes with a one-time treatment,” said Michael Parini, Freeline’s Chief Executive Officer. “The granting of the ILAP designation by UK regulators further highlights the significant need for more effective and less burdensome...

Continue reading

Zerify Outlines Strong Future Growth in Shareholder Update

EDISON, N.J., May 30, 2023 (GLOBE NEWSWIRE) — Zerify Inc., (OTC PINKSHEET: ZRFY), the 22-year-old cybersecurity company focused on Secure Video Conferencing & Endpoint GAP Security today and discusses its ambitious growth strategy and commitment to creating substantial value for its shareholders. With an unwavering focus on innovation, market expansion, and operational excellence, Zerify aims to achieve sustainable double-digit revenue growth over the next five years. The company plans to leverage its market-leading position, strong brand equity, and newly developing distribution channel to capitalize on emerging opportunities and enhance shareholder returns. “As a company, we are driven by a bold vision to reshape secure video conferencing, collaboration and endpoint security,” says Mark L. Kay, CEO of Zerify. “We have identified...

Continue reading

Ormat Resumes Operation at Its Heber 1 Power Plant in California and Completes Expansion of the Dixie Valley Power Plant in Nevada

RENO, Nev., May 30, 2023 (GLOBE NEWSWIRE) — Ormat Technologies (NYSE: ORA), a leading geothermal, energy storage, photovoltaic (PV) solar and recovered energy power company, today announced the successful resumption of operations at the Heber 1 power plant in California. This achievement comes after the plant temporarily shut down due to a fire incident that occurred in February 2022. This significant milestone is a testament to Ormat’s operational execution and its commitment to providing reliable and sustainable energy solutions to communities in California. In Nevada, Ormat completed a 6MW upgrade to the Dixie Valley power plant, which allows the Company to maximize its favorable long-term power purchase agreement. The upgrade involved the replacement of pre-acquisition equipment with Ormat’s state-of-the-art energy converters. “The...

Continue reading

Entourage Health Reports First Quarter 2023 Financial Results

Total revenue of $15.1 million in Q1 2023 represents a 24% sequential increase over Q4 2022. Net Revenue in medical accounted for $6.0 million, a 61% sequential increase over Q4 2022. Color Cannabis captured a 5.3% national market share in the pre-roll segment.1 Management will host a conference call on May 30, 2023, at 10 a.m. Eastern Time.TORONTO, May 30, 2023 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the three months ended March 31, 2023. The Company reported total revenue of $15.1 million (net revenue of $11.8 million, before excise duties and discounts), up 24% sequentially from Q4 2022.  The Company will host a conference call to discuss...

Continue reading

Gilat Satellite Networks to Present at the 2023 LD Micro Invitational Conference

Presentation will take place on Wednesday, June 7th at 12 p.m. PT PETAH TIKVA, Israel, May 30, 2023 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that it will be presenting at the 13th annual LD Micro Invitational on Wednesday, June 7th at 12 p.m. PT at the Luxe Sunset Boulevard Hotel in Los Angeles. Gil Benyamini, Chief Financial Officer, will be giving the Gilat presentation. The event is expected to feature more than 150 companies, which are presenting in half-hour increments and hosting private one-on-one meetings. We invite interested parties to register to watch the presentation remotely at https://ldinv13.sequireevents.com/. Management will also be meeting with investors and analysts in a one-on-one...

Continue reading

GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction

GreenLight Biosciences GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private TransactionLEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) — GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that the Company has entered into a definitive agreement (the “Merger Agreement”) to be acquired by a group of buyers led by Fall Line Capital, LLC (“Fall Line”) in an all-cash transaction valuing the Company at approximately $45.5 million. Pursuant to the terms of the Merger Agreement, and subject to the conditions set forth therein, Fall Line, together with its affiliates, agreed that it will commence a tender offer (the “Offer”) to acquire all of the outstanding shares of common stock of the Company (the “Company Common...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.